DiaMedica Therapeutics
DMAC
DMAC
36 hedge funds and large institutions have $60.6M invested in DiaMedica Therapeutics in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.86% less ownership
Funds ownership: 35.8% → 31.93% (-3.9%)
Holders
36
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.44M | |
| 2 | +$1.11M | |
| 3 | +$780K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$761K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$671K |
Top Sellers
| 1 | -$3.21M | |
| 2 | -$1.99M | |
| 3 | -$1.47M | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.17M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.01M |